Anima Biotech

About

Headcount over time

Offices

Q&A

What is Anima Biotech's primary focus?

Anima Biotech is a Tech.Bio company that operates at the intersection of mRNA biology and AI, focusing on the discovery of small molecule mRNA drugs and novel mRNA biology targets through its mRNA Lightning™ Platform.

How many employees does Anima Biotech currently have?

Anima Biotech has 68 employees, falling within the 51-200 employee bucket.

When was Anima Biotech founded?

Anima Biotech was founded in 2005.

What is the total amount of funding Anima Biotech has raised to date?

Anima Biotech has raised a total of $30,000,000 USD.

Has Anima Biotech established any strategic collaborations with pharmaceutical companies?

Yes, Anima Biotech has established strategic collaborations with pharmaceutical companies including Lilly, Takeda Pharmaceuticals, and AbbVie for partnered programs.

What is the status of Anima Biotech's product development?

Anima Biotech's product development is currently in the clinical trial stage.

What are some of the therapeutic areas Anima Biotech's wholly-owned pipeline programs target?

Anima Biotech's wholly-owned pipeline programs are in fibrosis (collagen I mRNA biology modulators), oncology (c-Myc mRNA biology modulators and mutation-agnostic mKras mRNA biology modulators), and neuroscience (Tau for Alzheimer's disease and Nav1.7 mRNA biology modulators for pain).

Team · 11

Yochi Slonim

Founder · Co-founder & CEO

Iris Alroy

Founder · Co-founder & CSO

Zeev Smilansky

Founder · Co-founder & CTO

Avi Eliassaf

Chief Operating Officer

Yossi Oulu

Vice President, Software Development

Generoso Ianniciello

Chief Business Officer

Yuval Tsadik

Vice President of Finance

Rick Lufkin

Vice President, Administration

Yoni Sheinberger

Vice President of Discovery

Inbal Shapira Lots

Vice President of Data Science & AI

Boaz Inbal

Vice President of Chemistry

Sectors & technology

Highlights

Tags